Mapping the Effect of (neuro)inflammation on Stress Sensitivity in the Brain of Healthy Men
Overview
- Phase
- Not Applicable
- Intervention
- Lipopolysaccharide (LPS)
- Conditions
- Inflammation
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Blood-oxygenation-level-dependent functional magnetic resonance imaging (BOLD fMRI) response to acute stress task
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
The goal of this interventional study is to determine the effects of inflammation on stress responses in the brain of healthy men. In order to achieve this goal, participants are injected with an inflammation-inducing agent, then observed inside a brain scanner.
Detailed Description
This interventional study is a randomized, triple-blind, placebo-controlled, cross-over study aiming to elucidate the impact of acute laboratory-induced inflammation using lipopolysaccharide (LPS) on stress responses in the brain of healthy men. Acute stress responses to a psychological task, the Maastricht Imaging Stress Task (MIST), are observed via blood-oxygenation-level-dependent functional magnetic resonance imaging (BOLD fMRI) and simultaneous positron emission tomography (PET) imaging using the radiotracer 18 Fluor (18F)-N,N-diethyl-2-\[4-(2-fluoroethoxy)phenyl\]-5,7-dimethylpyrazole\[1,5-a\]pyrimidine-3-acetamide (DPA)-714, which targets the 18 kilodalton (kDA) translocator protein (TSPO) of activated microglia. Every participant will receive 0.4 ng/kg body weight of LPS and saline on separate treatment visits, separated by a 2-3 months wash-out period.
Investigators
Lukas Van Oudenhove
Principal Investigator
Universitaire Ziekenhuizen KU Leuven
Eligibility Criteria
Inclusion Criteria
- •Age 18-45 years
- •BMI 18.5-25 kg/m2
- •Proficient in English and/or Dutch
Exclusion Criteria
- •Have previous or current neuropsychiatric disorders or have history of major head trauma
- •Have any disorder, which in the Investigator's opinion might jeopardise your safety or compliance with the study
- •Have any prior or current treatment(s) that might jeopardise your safety or that would compromise the integrity of the study
- •Have any prior and recent medication use (especially antibiotics, cardiovascular drugs, steroids, non-steroid anti-inflammatory drugs, centrally effective drugs)
- •Are participating in an interventional Trial with an investigational medicinal product (IMP) or device
- •Have current or previous infection or vaccination within the last 8 weeks
- •Have pathological values of blood indices and certain genetic profiles that will affect brain imaging results (we will conduct a blood screening before starting the study)
- •Had strong physical activity (e.g. swimming, football, running more than 8 km per hour, carrying heavy loads) 24h before the start of the experiment.
- •Are a smoker
- •Are a night-shift worker
Arms & Interventions
LPS then Saline
A crossover arm where the participant first receives the intervention (LPS), undergoes a wash-out period, then receives the placebo (saline).
Intervention: Lipopolysaccharide (LPS)
LPS then Saline
A crossover arm where the participant first receives the intervention (LPS), undergoes a wash-out period, then receives the placebo (saline).
Intervention: Placebo
Saline then LPS
A crossover arm where the participant first receives the placebo (saline), undergoes a wash-out period, then receives the intervention (LPS).
Intervention: Lipopolysaccharide (LPS)
Saline then LPS
A crossover arm where the participant first receives the placebo (saline), undergoes a wash-out period, then receives the intervention (LPS).
Intervention: Placebo
Outcomes
Primary Outcomes
Blood-oxygenation-level-dependent functional magnetic resonance imaging (BOLD fMRI) response to acute stress task
Time Frame: 2 hours after the single i.v bolus administration of LPS or saline
BOLD fMRI responses to the Montreal Imaging Stress Task (MIST) after administration of LPS compared to saline
Binding potential of [18F]-DPA-714 radiotracer
Time Frame: 2 hours after the single i.v bolus administration of LPS or saline
The change in \[18F\]-DPA-714 binding potential with and without LPS administration (%∆BPND)
Secondary Outcomes
- Concentration of serum cytokines(From 1 hour prior to intervention to 6 hours post-intervention)
- Concentration of serum C-reactive protein (CRP)(From 1 hour prior to intervention to 24 hours post-intervention)
- Concentration of serum free cortisol(From 1 hour prior to intervention to 24 hours post-intervention)
- Concentration of plasma Adrenocorticotropic Hormone (ACTH)(From 1 hour prior to intervention to 24 hours post-intervention)
- Pulse rate(From 1 hour prior to intervention to 6 hours post-intervention)
- Systolic blood pressure(From 1 hour prior to intervention to 6 hours post-intervention)
- Diastolic blood pressure(From 1 hour prior to intervention to 6 hours post-intervention)
- Body temperature(From 1 hour prior to intervention to 6 hours post-intervention)
- Scoring of the Generic Assessment of Side Effects (GASE) questionnaire(From 1 hour prior to intervention to 7 days post-intervention)
- Scoring of the Sickness Questionnaire (SicknessQ)(From 1 hour prior to intervention to 24 hours post-intervention)
- Scoring of the State-Trait Anxiety Inventory, State Anxiety subscale (STAI-S)(From 1 hour prior to intervention to 24 hours post-intervention)
- Scoring of the State-Trait-Anxiety and Depression Scale (STADI)(From 1 hour prior to intervention to 24 hours post-intervention)
- Scoring of the Stanford Sleepiness Scale (SSS)(From 1 hour prior to intervention to 24 hours post-intervention)
- Scoring of the Positive and Negative Affect Schedule (PANAS)(From 1 hour prior to intervention to 24 hours post-intervention)
- Scoring of the Multidimensional Mood Questionnaire (MDMQ)(From 1 hour prior to intervention to 24 hours post-intervention)